Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 101 entries
View as:

Study of Anti-PD-1 Antibody SHR-1210 Plus Nimotuzumab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03766178 Org: User:
Start: 09/30/21 End: 09/30/23 Due: 09/30/24

A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural Effusion

Phase: N/A Priority: Normal
NCT ID: NCT05330065 Org: User:
Start: 08/01/22 End: 08/31/24 Due: 08/31/25

Thrombolysis of Urokinase for Minor Stroke

Phase: N/A Priority: Normal
NCT ID: NCT04420351 Org: User:
Start: 10/04/20 End: 02/18/23 Due: 02/18/24

Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 Stage

Phase: N/A Priority: Normal
NCT ID: NCT06194981 Org: User:
Start: 01/11/24 End: 05/31/24 Due: 05/31/25

Primary Ovarian Insufficient Patients

Phase: N/A Priority: Normal
NCT ID: NCT03989154 Org: User:
Start: 01/01/10 End: 12/31/50 Due: 12/31/51

Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04654403 Org: User:
Start: 01/01/22 End: 12/31/22 Due: 12/31/23

A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure

Phase: N/A Priority: Normal
NCT ID: NCT02772029 Org: User:
Start: 05/31/16 End: 09/30/17 Due: 09/30/18

Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06718205 Org: User:
Start: 03/08/23 End: 09/30/25 Due: 09/30/26

The Application of Time-lapse System in IVF/ICSI

Phase: N/A Priority: Normal
NCT ID: NCT02974517 Org: User:
Start: 11/30/16 End: - Due: -

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Phase: N/A Priority: Normal
NCT ID: NCT05265962 Org: User:
Start: 12/01/22 End: 12/31/24 Due: 12/31/25

Prevention of Coronary Slow Flow or No-Reflow During PPCI in Patients With Acute STEMI

Phase: N/A Priority: Normal
NCT ID: NCT03406819 Org: User:
Start: 01/07/18 End: 12/31/19 Due: 12/31/20

the Research of Analgesia and Sedation Effect of Remifentanil on ICU Short Operation

Phase: N/A Priority: Normal
NCT ID: NCT02635802 Org: User:
Start: 12/31/15 End: 09/30/16 Due: 09/30/17

Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06231017 Org: User:
Start: 01/19/24 End: 01/19/26 Due: 01/19/27

Cortical Function Changes During Swallowing in Patients With Dysphagia in Lateral Medullary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06208020 Org: User:
Start: 05/31/23 End: 02/15/24 Due: 02/15/25

IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)

Phase: N/A Priority: Normal
NCT ID: NCT06078657 Org: User:
Start: 10/31/23 End: 10/31/25 Due: 10/31/26

Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia

Phase: N/A Priority: Normal
NCT ID: NCT06213662 Org: User:
Start: 11/01/22 End: 07/01/24 Due: 07/01/25

Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT03006406 Org: User:
Start: 01/31/16 End: 01/31/18 Due: 01/31/19

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Phase: N/A Priority: Normal
NCT ID: NCT04984018 Org: User:
Start: 12/01/21 End: 12/31/23 Due: 12/31/24

Treatment of Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03278444 Org: User:
Start: 07/18/17 End: 07/31/21 Due: 07/31/22

Treatment of Advanced Intrahepatic Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03940378 Org: User:
Start: 02/01/19 End: 02/01/23 Due: 02/01/24

Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05024812 Org: User:
Start: 06/01/22 End: 02/28/25 Due: 02/28/26

Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT04850950 Org: User:
Start: 04/26/21 End: 12/31/22 Due: 12/31/23

Site Selection of Short Peripheral Venous Catheters

Phase: N/A Priority: Normal
NCT ID: NCT03290573 Org: User:
Start: 09/29/17 End: 01/06/19 Due: 01/06/20

Apatinib Combined With Docetaxel in the Treatment of Advanced Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03193424 Org: User:
Start: 10/31/16 End: 12/30/19 Due: 12/30/20

A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC

Phase: N/A Priority: Normal
NCT ID: NCT03817658 Org: User:
Start: 10/31/19 End: 10/31/21 Due: 10/31/22